Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A neurasthenia and drug technology, applied in drug combinations, nervous system diseases, pharmaceutical formulations, etc., can solve the problems of unable to fundamentally cure neurasthenia patients, unable to improve cerebral vascular tone, and improve brain cell function, etc., to achieve recovery Brain cell function, increase cerebral blood flow supply, and improve the effect of tension
Inactive Publication Date: 2010-09-15
尹秉安
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, drugs such as oryzanol and deer antler tablets are often taken for the treatment of neurasthenia. The above-mentioned drugs only have a certain regulatory effect on patients with neurasthenia, can stabilize emotions, relieve anxiety and tension, but cannot dilate cerebral blood vessels and cannot improve cerebral blood vessels. Tension and improving brain cell function cannot fundamentally cure neurasthenia patients
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0006] A medicine for treating neurasthenia according to the invention, the composition and content of the medicine are: vitamin B 1 12 mg, B vitamins 6 10 mg, 9 mg of rutin, 10 mg of dimethazole, and 4 mg of chlordiazepoxide were mixed and packed into capsules; the patient took 2 capsules three times a day, two weeks as a course of treatment. After taking one course of treatment, patients generally feel dizziness, drowsiness, fatigue, irritability, insomnia, dreaminess, morning fatigue and other symptoms are significantly relieved; after taking two courses of treatment, the patient's symptoms and signs are significantly turned negative at the same time; Basically recover from illness, the cure rate reaches 99.5%.
[0007] Vitamin B in the above-mentioned drugs 1 and vitamin B 6 It has the effect of nourishing the central nervous system; rutin and dimethazole have the effect of selectively expanding cerebral blood vessels to increase cerebral blood flow, improve cerebral ...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicine for treating neurasthenia, which consists of vitamin B1, vitamin B6, rutin, dibazol and chlordiazepoxide, and is loaded into capsules after the mixing; a patient orally takes 2 particles for three times every day, and two weeks are a treatment course. The medicine has functions of dilating cerebral vessels, increasing the supply of cerebral blood flow, strengthening the aerobic metabolism of brain cells, improving the tensity of the cerebral vessels, and restoring functions of the brain cells, thereby improving and curing dizziness, headache, drowsiness, dreaminess or insomnia, anxiety, amnesia, abnormal sensation, endocrine dyscrasia, sequela of cerebrovascular disease and the like, of patients, and radically curing neurasthenia patients. The medicine can also treat intestinal, gastric and cardiac neurosis, angioneurotic headache, climacteric syndrome, cerebral thrombosis or cerebral hemorrhage and cerebral trauma rehabilitation, moyamoya disease and the like.
Description
1. Technical field [0001] The invention relates to a medicine for treating human diseases, specifically a medicine for treating neurasthenia. 2. Background technology [0002] Neurasthenia is due to the long-term irregular state of excitation and inhibition of the human cerebral cortex, causing cerebral vasospasm, decreased cerebral blood flow, insufficient oxygen supply to the brain, and decreased brain cell function. It is characterized by dizziness, drowsiness, fatigue, and drowsiness in the daytime, and insomnia and dreaminess at night, and the normal person's excitation and inhibition time rules are lost. At present, drugs such as oryzanol and deer antler tablets are often taken for the treatment of neurasthenia. The above-mentioned drugs only have a certain regulatory effect on patients with neurasthenia, can stabilize emotions, relieve anxiety and tension, but cannot dilate cerebral blood vessels and cannot improve cerebral blood vessels. Tension and improving brain ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more